
Pulmonologist

No OPD information available
Anorexia
Hypertension
Obesity
Abdominal Obesity Metabolic Syndrome
Cystic Fibrosis
Familial Dysautonomia
Low Blood Pressure
Metabolic Syndrome
Ovarian Cysts
Polycystic Ovary Syndrome
Postural Orthostatic Tachycardia Syndrome (POTS)
Silicosis
Nina Eikelis is a female medical professional who helps people with various health issues like anorexia, hypertension, obesity, and more. She also works with conditions such as cystic fibrosis, low blood pressure, ovarian cysts, and polycystic ovary syndrome.
Nina Eikelis uses special skills and treatments to care for her patients. She talks to them in a way that makes them feel comfortable and safe, which helps build trust. Patients trust Nina Eikelis because she listens to their concerns and explains things clearly.
To stay updated with the latest medical knowledge, Nina Eikelis reads research papers and attends conferences. This helps her provide the best care for her patients. She also collaborates with other medical professionals to share knowledge and improve patient outcomes.
Nina Eikelis has positive relationships with her colleagues. They work together to provide the best care for patients. Nina Eikelis's work has made a positive impact on many patients' lives. She has helped improve their health and well-being through her treatments and care.
One of Nina Eikelis's notable publications is about lung volume changes in healthy adults using noninvasive positive pressure ventilation. She has also conducted a clinical trial focusing on the link between the serotonin transporter and the sympathetic nervous system in patients with major depressive disorder.
In summary, Nina Eikelis is a dedicated medical professional who uses her skills and knowledge to help patients with various health conditions. She communicates effectively, stays updated with the latest research, collaborates with colleagues, and makes a positive impact on patients' lives.
Enrollment Status: Completed
Published: September 14, 2023
Intervention Type: Drug
Study Drug: Selective Serotonin Re-Uptake Inhibitor (SSRI) Antidepressant
Study Phase: Phase 4
